← Back to all stories
Personalized Brain Stimulation Therapy Offers Hope with High PTSD Remission Rates

Photo: National Cancer Institute / Unsplash
A newly cleared FDA treatment using targeted magnetic brain stimulation achieved a 68% remission rate in a recent clinical trial for post-traumatic stress disorder. Patients experienced more than a 50% reduction in symptoms, opening the door for more precise and effective mental health therapies in the future.
A newly cleared FDA treatment using targeted magnetic brain stimulation achieved a 68% remission rate in a recent clinical trial for post-traumatic stress disorder. Patients experienced more than a 50% reduction in symptoms, opening the door for more precise and effective mental health therapies in the future.